Pneumocystis jiroveci pneumonia in patients with rheumatoid arthritis treated with infliximab: A retrospective review and case–control study of 21 patients
…, K Saito, N Sekiguchi, M Inoo… - Arthritis Care & …, 2009 - Wiley Online Library
Objective To establish proper management of Pneumocystis jiroveci pneumonia (PCP) in
rheumatoid arthritis (RA) patients treated with infliximab. PCP has been observed in 0.4% of …
rheumatoid arthritis (RA) patients treated with infliximab. PCP has been observed in 0.4% of …
[HTML][HTML] Comparison of adding tocilizumab to methotrexate with switching to tocilizumab in patients with rheumatoid arthritis with inadequate response to methotrexate …
Objective To compare the efficacy and safety between tocilizumab added to methotrexate
and tocilizumab switched from methotrexate in patients with active rheumatoid arthritis (RA). …
and tocilizumab switched from methotrexate in patients with active rheumatoid arthritis (RA). …
Association of higher methotrexate dose with lymphoproliferative disease onset in rheumatoid arthritis patients
T Kameda, H Dobashi, N Miyatake, M Inoo… - Arthritis care & …, 2014 - Wiley Online Library
Objective Methotrexate (MTX) is used as an anchor drug for rheumatoid arthritis (RA).
Lymphoproliferative disease (LPD) occasionally develops in patients treated with MTX, and is …
Lymphoproliferative disease (LPD) occasionally develops in patients treated with MTX, and is …
Tocilizumab discontinuation after attaining remission in patients with rheumatoid arthritis who were treated with tocilizumab alone or in combination with methotrexate …
Objective To evaluate the sustained remission and low disease activity after discontinuation
of tocilizumab in patients with rheumatoid arthritis who were treated with tocilizumab alone …
of tocilizumab in patients with rheumatoid arthritis who were treated with tocilizumab alone …
Longterm safety and efficacy of subcutaneous tocilizumab monotherapy: results from the 2-year open-label extension of the MUSASHI study
A Ogata, K Amano, H Dobashi, M Inoo, T Ishii… - The Journal of …, 2015 - jrheum.org
Objective. To evaluate the longterm safety and efficacy of subcutaneous tocilizumab (TCZ-SC)
as monotherapy in patients with rheumatoid arthritis (RA). Methods. Of 346 patients who …
as monotherapy in patients with rheumatoid arthritis (RA). Methods. Of 346 patients who …
Sustained discontinuation of infliximab with a raising-dose strategy after obtaining remission in patients with rheumatoid arthritis: the RRRR study, a randomised …
…, K Amano, K Ushio, T Atsumi, M Inoo… - Annals of the …, 2020 - ard.bmj.com
Objectives The aim of this study is to determine whether the ‘programmed’ infliximab (IFX)
treatment strategy (for which the dose of IFX was adjusted based on the baseline serum …
treatment strategy (for which the dose of IFX was adjusted based on the baseline serum …
[HTML][HTML] Humoral immune response against BNT162b2 mRNA COVID-19 vaccine in patients with rheumatic disease undergoing immunosuppressive therapy: a …
…, M Mizusaki, R Mino, K Chujo, Y Nomura, M Inoo… - Medicine, 2022 - journals.lww.com
We investigated serum total antibody titers against severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) spike protein receptor-binding domain after BNT162b2 mRNA …
coronavirus 2 (SARS-CoV-2) spike protein receptor-binding domain after BNT162b2 mRNA …
A case of femoral nerve palsy caused by iliopectineal bursitis associated with rheumatoid arthritis
…, Y Kawaguchi, S Todo, M Inoo… - Modern …, 2004 - Taylor & Francis
We report the case of a 46-year-old woman with rheumatoid arthritis who developed femoral
nerve palsy caused by an enlarged iliopectineal bursa. Surgical excision revealed that the …
nerve palsy caused by an enlarged iliopectineal bursa. Surgical excision revealed that the …
Immunogenicity against the BNT162b2 mRNA COVID-19 vaccine in rheumatic disease patients receiving immunosuppressive therapy
…, T Miyagi, M Mizusaki, R Mino, Y Nomura, M Inoo… - Internal …, 2022 - jstage.jst.go.jp
Objective To investigate the serum total antibody (immunoglobulin M and immunoglobulin G)
titre against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein …
titre against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein …
Predictive value of serum amyloid a levels for requirement of concomitant methotrexate in tocilizumab initiation: A post hoc analysis of the SURPRISE study
Objectives: To identify predictive factors for remission by tocilizumab monotherapy in rheumatoid
arthritis (RA) patients. Methods: This is a post hoc analysis of the SURPRISE study, a 2-…
arthritis (RA) patients. Methods: This is a post hoc analysis of the SURPRISE study, a 2-…